Invalid Symbol

Stock Research for ABSCF

ABSCF
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ABSCF Stock Chart & Research Data

The ABSCF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABSCF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ABSCF Due diligence Resources & Stock Charts

The ABSCF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABSCF Detailed Price Forecast - CNN Money CNN View ABSCF Detailed Summary - Google Finance
Yahoo View ABSCF Detailed Summary - Yahoo! Finance Zacks View ABSCF Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ABSCF Trends & Analysis - Trade-Ideas Barrons View ABSCF Major Holders - Barrons
NASDAQ View ABSCF Call Transcripts - NASDAQ Seeking View ABSCF Breaking News & Analysis - Seeking Alpha
Spotlight View ABSCF Annual Report - CompanySpotlight.com OTC Report View ABSCF OTC Short Report - OTCShortReport.com
TradeKing View ABSCF Fundamentals - TradeKing Charts View ABSCF SEC Filings - Bar Chart
WSJ View Historical Prices for ABSCF - The WSJ Morningstar View Performance/Total Return for ABSCF - Morningstar
MarketWatch View the Analyst Estimates for ABSCF - MarketWatch CNBC View the Earnings History for ABSCF - CNBC
StockMarketWatch View the ABSCF Earnings - StockMarketWatch MacroAxis View ABSCF Buy or Sell Recommendations - MacroAxis
Bullish View the ABSCF Bullish Patterns - American Bulls Short Pains View ABSCF Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ABSCF Stock Mentions - StockTwits PennyStocks View ABSCF Stock Mentions - PennyStockTweets
Twitter View ABSCF Stock Mentions - Twitter Invest Hub View ABSCF Investment Forum News - Investor Hub
Yahoo View ABSCF Stock Mentions - Yahoo! Message Board Seeking Alpha View ABSCF Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ABSCF - SECform4.com Insider Cow View Insider Transactions for ABSCF - Insider Cow
CNBC View ABSCF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABSCF - OTC Markets
Yahoo View Insider Transactions for ABSCF - Yahoo! Finance NASDAQ View Institutional Holdings for ABSCF - NASDAQ


Stock Charts

FinViz View ABSCF Stock Insight & Charts - FinViz.com StockCharts View ABSCF Investment Charts - StockCharts.com
BarChart View ABSCF Stock Overview & Charts - BarChart Trading View View ABSCF User Generated Charts - Trading View


Latest Financial News for ABSCF

AB Science announces that based on interim analysis, IDMC recommended the continuation of the masitinib phase 3 study in progressive multiple sclerosis with no requirement to increase the sample size
Posted on Thursday January 04, 2018

Paris, January 4 2018, 5.45 pm. AB Science announces that based on interim analysis, IDMC recommended the continuation of the masitinib phase 3 study in progressive forms of multiple sclerosis with no ...


AB Science announces the publication of Preclinical data showing that masitinb is capable of counteracting resistance to oncology treatments
Posted on Tuesday November 21, 2017

Paris, 21 November 2017, 5.45pm Preclinical data published in Nature Communications shows that masitinib is capable of counteracting resistance to oncology treatments, including gemcitabine Phase 3 clinical ...


AB Science reports its revenue for the first half of 2017
Posted on Thursday August 31, 2017

Paris, August 31 2017, 6pm Net loss of 13.5M€ in the first half of 2017, a decrease of 8.4% as compared with the first half of 2016 (14.7M€), due to R&D costs decrease Cash position of 49.3M€ as of 30 ...


AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients
Posted on Wednesday July 12, 2017

Paris, 12 July 2017, 5.45pm AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients with pain until 2033 Recruitment target before possible ...


AB Science Plunges After Regulator Suspends French Drug Trials
Bloomberg - May 16, 2017
AB Science has corrected the deficiencies and it's confident it will be allowed to restart studies in France in a few months after independent audits are conducted, it said in a statement Monday.
AB Science Resumes Trading after Clinic and Stock Disasters - Labiotech.eu (blog)

Analysts lay into AB Science after regulatory misstep
FierceBiotech - May 15, 2017
AB has said the regulatory failings predate the clinical trial it hopes to use to win approval of masitinib in amyotrophic lateral sclerosis (ALS).
AB Science provides the summary of both conference calls held on May 12, 2017 ... - GlobeNewswire (press release)
AB Science suspends French masitinib trials after ANSM finds deviations - In-PharmaTechnologist.com

AB Science trumpets phase 3 ALS data, but investors seem unmoved
FierceBiotech - May 19, 2017
AB Science says it will ask the committee to re-examine its mastocytosis decision, but going on experience to date investors could be forgiven for not leaping at the latest clinical data for masitinib in ALS.

Regulators order AB Science to halt trial work on PhIII ALS drug, demanding ...
Endpoints News - May 12, 2017
Just weeks after laying out claims on positive Phase III data for their ALS drug masitinib, French regulatory authorities are dropping the hammer on AB Science, ordering a halt to clinical research work on the drug until the biotech can prove it's ...
AB Science announces that ANSM requested the temporary suspension of clinical ... - GlobeNewswire (press release)
French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug ... - TheStreet.com

Enter a stock symbol to view the stock details.